Suspension of trading
Sector Adaptimmune Therapeutics plc Börse Stuttgart
Stocks
473A
US00653A1079
Pharmaceuticals
|
Market Closed -
Börse Stuttgart
05:04:00 2026-05-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 EUR | -.--% |
|
-41.18% | -9.09% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.67% | -4.78% | +14.20% | +29.18% | +2.89% | +36.76% | -4.34% | +19.73% | +98.86% | 79.3B | |
| -0.90% | +2.39% | +44.18% | +76.58% | -0.19% | -18.98% | -35.69% | -44.60% | +58.02% | 59.21B | |
| -3.35% | -4.92% | +153.24% | +192.41% | +367.92% | +472.81% | +18.97% | -63.90% | - | 55.09B | |
| -6.78% | -4.19% | -4.07% | +8.23% | -12.33% | -4.50% | +28.86% | +2.06% | - | 49.86B | |
| -2.43% | -2.35% | -13.47% | -11.34% | -9.26% | +8.03% | +163.45% | +122.19% | +195.44% | 47.9B | |
| -1.35% | +0.79% | +4.43% | +11.48% | +24.15% | +65.25% | -18.47% | -36.33% | -28.63% | 32.28B | |
| -2.64% | -2.69% | -2.15% | +28.56% | +25.92% | +46.99% | +92.55% | +64.34% | +52.92% | 25.21B | |
| -0.09% | +4.98% | +19.58% | +43.62% | +40.98% | +18.59% | +209.35% | +76.66% | - | 23.87B | |
| -0.34% | +1.35% | -0.13% | +6.54% | +40.08% | +60.10% | +122.64% | +143.45% | +364.81% | 16.89B | |
| +2.73% | 0.00% | +40.30% | +12.58% | -7.45% | -0.48% | +845.45% | +514.02% | +7,031.43% | 16.17B | |
| -2.64% | -6.01% | -8.31% | +15.61% | +0.14% | +47.99% | +150.98% | +51.74% | - | 14.97B | |
| -0.96% | -3.05% | +5.37% | +12.87% | +8.81% | +10.97% | -31.56% | -22.57% | -32.46% | 12.52B | |
| -3.51% | -4.21% | -12.49% | -15.12% | +8.97% | +64.10% | +153.88% | +729.25% | +2,607.76% | 10.42B | |
| -1.68% | +1.41% | -3.25% | +13.73% | +42.56% | +137.96% | +179.65% | +505.97% | - | 10.4B | |
| -7.66% | -2.89% | +65.41% | +111.43% | +345.71% | +424.21% | +565.94% | +26.70% | - | 8.87B | |
| -1.04% | +0.38% | -0.38% | +4.06% | -7.01% | -18.28% | -23.28% | -51.58% | -47.89% | 6.91B | |
| -1.40% | +2.85% | +8.98% | +32.67% | +3.39% | -1.54% | +69.96% | -11.18% | - | 6.23B | |
| -2.16% | -1.20% | -3.51% | +61.39% | +89.28% | +133.14% | +346.43% | +510.48% | - | 6.09B | |
| -3.10% | -0.72% | +4.01% | -8.55% | -32.42% | -47.84% | -35.66% | -74.04% | - | 5.71B | |
| Average | -2.16% | -0.09% | +16.42% | +32.94% | +49.06% | +75.54% | +147.32% | +129.60% | +1,030.03% | 25.68B | |
| Weighted average by Cap. | -2.29% | -1.17% | +26.55% | +44.45% | +54.19% | +81.71% | +87.86% | +61.95% | +545.39% |
- Stock Market
- Stocks
- ADAPY Stock
- 473A Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
